印度个性化医学的制度化:研究趋势和政府干预措施的分析
Ishita Goyal1,2, Madhavi Yennappu1,2
1CSIR-National Institute of Science Communication & Policy Research (NIScPR), Dr KS Krishnan Marg, Pusa Gate, New Delhi- 110012, India.
Personalized medicine
|July 14, 2023
概括
个性化医疗 (PM) 可以提高医疗保健的可访问性和可负担性. 本研究分析了印度的PM研究趋势和政府举措,并提出了将其纳入国家医疗保健系统的政策框架.
科学领域:
- 卫生政策 卫生政策
- 创新系统创新系统
- 基因组医学是基因组医学.
背景情况:
- 在全球范围内,医疗保健系统面临着负担能力和可访问性方面的挑战.
- 技术进步,特别是个性化医疗 (PM),提供了潜在的解决方案.
- 印度充满活力的医疗保健行业为PM实施提供了一个独特的背景.
研究的目的:
- 分析印度个性化医学 (PM) 的研究趋势和政府干预措施.
- 评估印度医疗保健部门内PM的实施和制度化.
- 提出一个综合的政策框架,以推进印度的PM采用.
主要方法:
- 利用部门创新系统框架分析政府干预和研究趋势.
- 使用科学网络数据库对PM研究进行了文献计量分析.
- 汇编和分析了印度政府资助的旨在使PM制度化的倡议.
主要成果:
- 确定了关键的研究网络,系统边界和政府倡议,促进印度的PM采用.
- 揭示了印度医疗保健部门内PM研发的动态格局.
- 突出了阻碍PM广泛整合的政策差距.
结论:
- 个性化医疗 (PM) 具有很大的潜力来应对印度的医疗保健挑战.
- 综合政策框架对于有效地将PM纳入印度医疗保健系统至关重要.
- 进一步的政府干预和战略规划是必要的,以促进PM采用和最大限度地提高其益处.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Microorganisms in Medicine and Therapeutics
62
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
62
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
189
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
189
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K


